Mark Sirgo

Type: Person
Name: Mark Sirgo
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy

By a News Reporter-Staff News Editor at Diabetes Week BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that it has completed a pre-specified interim analysis of the ongoing initial pivotal Phase 3 trial for Clonidine Topical Gel for ... [Published Pharmacy Choice - Aug 18 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

BioDelivery Sciences to File Quarterly Report

BioDelivery Sciences International, Inc. reported that it has filed its Quarterly Report on Form 10-Q for the quarter ended June 30, with the U.S. Securities and Exchange Commission and, in connection therewith, is providing a review of BDSI's recent ... [Published Individual.com - Aug 12 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

The Quiet Epidemic of Senior Drug Abuse

NEW YORK – (DGIwire)Unfortunately, when drugs come from a doctor’s prescription pad, misuse is harder to identify. That’s because many older adults take them for non-medical reasons even though we often assume these drugs are only being used to treat ... [Published Boston Globe - Aug 12 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 2 reports

BioDelivery Sciences Provides Business Review and Update in Conjunction with Filing of Second Quarter 2014 Financials [Global Data Point]

In June, BDSI received approval of the New Drug Application (NDA) for BUNAVAIL? (buprenorphine and naloxone) buccal film from the U.S. Food and Drug Administration (FDA). BUNAVAIL is indicated for the maintenance treatment of opioid dependence and should ... [Published Pharmacy Choice - Aug 08 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

BioDelivery Sciences updates on Clonidine Topical Gel Phase 3 trial for PDN treatment

Published on August 6, 2014 at 9:14 AM · No CommentsBioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has completed a pre-specified interim analysis of the ongoing initial pivotal Phase 3 trial for Clonidine Topical Gel ... [Published News-Medical.Net - Aug 06 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

An Innovative Treatment for Prescription Pill Abuse

NEW YORK – (DGIwire)Cobain isn’t the only celebrity to succumb to a drug overdose—far from it. The lives of Whitney Houston, Heath Ledger, Anna Nicole Smith and Michael Jackson were cut short due to their reliance on drugs, most of which were legal, prescription ... [Published Boston Globe - Aug 05 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 2 reports

Reckitt Benckiser Confirms Plans to Spin Off Suboxone Unit

(Updates with CFO comments in second paragraph)July 28 (Bloomberg) -- Reckitt Benckiser Group Plc will spin off its pharmaceutical unit, after concluding the business that once accounted for a fifth of earnings doesn’t fit into Chief Executive Officer ... [Published Washington Post - Jul 28 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA buprenorphine in opioid-experienced...

Endo and BioDelivery Sciences announce positive top-line results from the Phase III clinical trial of BEMA buprenorphine in opioid-experienced patients with chronic painBy a News Reporter-Staff News Editor at Biotech Week Endo Pharmaceuticals Inc., a ... [Published Pharmacy Choice - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

BioDelivery Sciences Appoints Charles J. Bramlage And Dr. Barry I. Feinberg To Its Board Of Directors

BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) announced that its Board of Directors has appointed Charles J. (Chuck) Bramlage and Dr. Barry I. Feinberg as members of the Board.Mr. Bramlage is a veteran pharmaceutical industry executive ... [Published Benzinga.com - Jul 22 2014]
First reported Jun 11 2014 - Updated Jun 12 2014 - 1 reports

BioDelivery Sciences Featured on Bloomberg TV, TheStreet.com and Business News Network

RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding ... [Published PR Newswire: Entertainment & Media - Jun 11 2014]
First reported Jun 10 2014 - Updated Jun 10 2014 - 1 reports

BioDelivery Sciences to Present at the William Blair and Wells Fargo Healthcare Conferences

RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34th ... [Published PR Newswire: General Business - Jun 10 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

BioDelivery Sciences to Present at the Bank of America Merrill Lynch 2014 Health Care Conference

RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch 2014 Health Care Conference.  ... [Published PR Newswire: General Business - May 08 2014]

More Content

All (18) | News (13) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
BioDelivery Sciences Provides Update on Ongoing... [Published Pharmacy Choice - Aug 18 2014]
The Quiet Epidemic of Senior Drug Abuse [Published Boston Globe - Aug 12 2014]
BioDelivery Sciences to File Quarterly Report [Published Individual.com - Aug 12 2014]
BioDelivery Sciences Provides Business Review a... [Published Pharmacy Choice - Aug 08 2014]
BioDelivery Sciences Provides Business Review a... [Published Wall Street Select - Aug 07 2014]
BioDelivery Sciences updates on Clonidine Topic... [Published News-Medical.Net - Aug 06 2014]
BioDelivery Sciences Provides Update on Ongoing... [Published TickerTech.com - Aug 06 2014]
An Innovative Treatment for Prescription Pill A... [Published Boston Globe - Aug 05 2014]
Reckitt Benckiser Confirms Plans to Spin Off Su... [Published Washington Post - Jul 28 2014]
Reckitt Benckiser to Spin Off Pharmaceutical Unit [Published Bloomberg - Jul 28 2014]
Endo and BioDelivery Sciences announce positive... [Published Pharmacy Choice - Jul 23 2014]
BioDelivery Sciences Appoints Charles J. Bramla... [Published Benzinga.com - Jul 22 2014]
BioDelivery Sciences Featured on Bloomberg TV, ... [Published PR Newswire: Entertainment & Media - Jun 11 2014]
BioDelivery Sciences to Present at the William ... [Published PR Newswire: General Business - Jun 10 2014]
US FDA approves BioDelivery Sciences' Bunavail ... [Published PharmaBiz - Jun 10 2014]
BioDelivery Sciences to Present at the Bank of ... [Published PR Newswire: General Business - May 08 2014]
BioDelivery Sciences to Present at the 26th Ann... [Published PR Newswire: General Business - Mar 05 2014]
BioDelivery Sciences to Present at the Cowen an... [Published PR Newswire: Health - Feb 28 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
BioDelivery Sciences Featured on Bloomberg TV, ... [Published PR Newswire: Entertainment & Media - Jun 11 2014]
RALEIGH, N.C., June 11, 2014 /PRNewswire/ -- Dr. Mark A. Sirgo, President and Chief Executive Officer of BioDelivery Sciences International, Inc. (NASDAQ: BDSI) was interviewed on Bloomberg TV, TheStreet.com and Business News Network on June 11 regarding ...
BioDelivery Sciences to Present at the William ... [Published PR Newswire: General Business - Jun 10 2014]
RALEIGH, N.C., June 10, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at two important upcoming healthcare conferences: 34th ...
BioDelivery Sciences to Present at the Bank of ... [Published PR Newswire: General Business - May 08 2014]
RALEIGH, N.C., May 8, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Bank of America Merrill Lynch 2014 Health Care Conference.  ...
BioDelivery Sciences to Present at the 26th Ann... [Published PR Newswire: General Business - Mar 05 2014]
RALEIGH, N.C., March 5, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the 26th Annual ROTH Conference.  The presentation ...
BioDelivery Sciences to Present at the Cowen an... [Published PR Newswire: Health - Feb 28 2014]
RALEIGH, N.C., Feb. 28, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced that Dr. Mark A. Sirgo, President and Chief Executive Officer of BDSI, will present at the Cowen and Company 34th Annual Health Care Conference.  ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.